SARS-CoV-2 infects cells via its spike protein binding to its surface receptor on target cells
and results in acute symptoms involving especially the lungs known as COVID-19. However …

Post COVID-19 Syndrome (PCS) is a complex of various symptoms developing a month or
more after the acute phase of the disease. The cases of PCS development among patients …

Background While the leading symptoms during coronavirus disease 2019 (COVID-19) are
acute and the majority of patients fully recover, a significant fraction of patients now …

Many patients with SARS-CoV-2 infection develop neurological signs and symptoms;
although, to date, little evidence exists that primary infection of the brain is a significant …

Abstract Objective Most SARS‐CoV‐2‐infected individuals never require hospitalization.
However, some develop prolonged symptoms. We sought to characterize the spectrum of …

Since late 2019, the novel coronavirus SARS-CoV-2 has introduced a wide array of health
challenges globally. In addition to a complex acute presentation that can affect multiple …

Background As defined by the WHO, the term post-COVID syndrome (PCS) embraces a
group of symptoms that can occur following the acute phase of a SARS-CoV-2 infection and …

Background and purpose Neuropathological studies can elucidate the mechanisms of
nervous system damage associated with SARS‐CoV‐2 infection. Despite literature on this …

As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread
globally, it became evident that the SARS-CoV-2 virus infects multiple organs including the …

Background: Atherosclerotic cardiovascular diseases are characterized by a dysregulated
inflammatory and thrombotic state, leading to devastating complications with increased …